Retinopathy of Prematurity Reactivated 28 Months after Injection of Ranibizumab

M. H. Ji; D. M. Moshfeghi; N. F. Callaway; Z. Bodnar; I. H. Schachar; G. M. Amorelli; L. Orazi; F. Molle; Domenico Lepore

doi:10.1016/j.oret.2019.06.017

Retinopathy of Prematurity Reactivated 28 Months after Injection of Ranibizumab

M. H. Ji
, D. M. Moshfeghi^*
, N. F. Callaway
, Z. Bodnar
, I. H. Schachar
, G. M. Amorelli
, L. Orazi
, F. Molle
, Domenico Lepore

^*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivista › Articolo

5 Citazioni (Scopus)

Abstract

N/A

Lingua originale	Inglese
pagine (da-a)	913-915
Numero di pagine	3
Rivista	Ophthalmology Retina
Volume	3
Numero di pubblicazione	10
DOI	https://doi.org/10.1016/j.oret.2019.06.017
Stato di pubblicazione	Pubblicato - 2019

All Science Journal Classification (ASJC) codes

Oftalmologia

Keywords

Angiogenesis Inhibitors
Fluorescein Angiography
Follow-Up Studies
Fundus Oculi
Humans
Infant
Intravitreal Injections
Male
Newborn
Ranibizumab
Recurrence
Retina
Retinopathy of Prematurity
Time Factors
Vascular Endothelial Growth Factor A

Accesso al documento

10.1016/j.oret.2019.06.017

Altri file e collegamenti

Cita questo

@article{5d72a24694324123ac1e90978917502c,

title = "Retinopathy of Prematurity Reactivated 28 Months after Injection of Ranibizumab",

abstract = "N/A",

keywords = "Angiogenesis Inhibitors, Fluorescein Angiography, Follow-Up Studies, Fundus Oculi, Humans, Infant, Intravitreal Injections, Male, Newborn, Ranibizumab, Recurrence, Retina, Retinopathy of Prematurity, Time Factors, Vascular Endothelial Growth Factor A, Angiogenesis Inhibitors, Fluorescein Angiography, Follow-Up Studies, Fundus Oculi, Humans, Infant, Intravitreal Injections, Male, Newborn, Ranibizumab, Recurrence, Retina, Retinopathy of Prematurity, Time Factors, Vascular Endothelial Growth Factor A",

author = "Ji, \{M. H.\} and Moshfeghi, \{D. M.\} and Callaway, \{N. F.\} and Z. Bodnar and Schachar, \{I. H.\} and Amorelli, \{G. M.\} and L. Orazi and F. Molle and Domenico Lepore",

year = "2019",

doi = "10.1016/j.oret.2019.06.017",

language = "English",

volume = "3",

pages = "913--915",

journal = "Ophthalmology Retina",

issn = "2468-6530",

publisher = "Elsevier Inc.",

number = "10",

}

TY - JOUR

T1 - Retinopathy of Prematurity Reactivated 28 Months after Injection of Ranibizumab

AU - Ji, M. H.

AU - Moshfeghi, D. M.

AU - Callaway, N. F.

AU - Bodnar, Z.

AU - Schachar, I. H.

AU - Amorelli, G. M.

AU - Orazi, L.

AU - Molle, F.

AU - Lepore, Domenico

PY - 2019

Y1 - 2019

N2 - N/A

AB - N/A

KW - Angiogenesis Inhibitors

KW - Fluorescein Angiography

KW - Follow-Up Studies

KW - Fundus Oculi

KW - Humans

KW - Infant

KW - Intravitreal Injections

KW - Male

KW - Newborn

KW - Ranibizumab

KW - Recurrence

KW - Retina

KW - Retinopathy of Prematurity

KW - Time Factors

KW - Vascular Endothelial Growth Factor A

KW - Angiogenesis Inhibitors

KW - Fluorescein Angiography

KW - Follow-Up Studies

KW - Fundus Oculi

KW - Humans

KW - Infant

KW - Intravitreal Injections

KW - Male

KW - Newborn

KW - Ranibizumab

KW - Recurrence

KW - Retina

KW - Retinopathy of Prematurity

KW - Time Factors

KW - Vascular Endothelial Growth Factor A

UR - https://publicatt.unicatt.it/handle/10807/173889

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85071401463&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85071401463&origin=inward

U2 - 10.1016/j.oret.2019.06.017

DO - 10.1016/j.oret.2019.06.017

M3 - Article

SN - 2468-6530

VL - 3

SP - 913

EP - 915

JO - Ophthalmology Retina

JF - Ophthalmology Retina

IS - 10

ER -

Retinopathy of Prematurity Reactivated 28 Months after Injection of Ranibizumab

Abstract

All Science Journal Classification (ASJC) codes

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo